- IBDEI2TS ; ; 04-FEB-2020
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.3,45067,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,45067,1,3,0)
- ;;=3^Sezary Disease,Extranodal/Solid Organ Sites
- ;;^UTILITY(U,$J,358.3,45067,1,4,0)
- ;;=4^C84.19
- ;;^UTILITY(U,$J,358.3,45067,2)
- ;;=^5001640
- ;;^UTILITY(U,$J,358.3,45068,0)
- ;;=C84.13^^170^2245^29
- ;;^UTILITY(U,$J,358.3,45068,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,45068,1,3,0)
- ;;=3^Sezary Disease,Intra-Abdominal Lymph Nodes
- ;;^UTILITY(U,$J,358.3,45068,1,4,0)
- ;;=4^C84.13
- ;;^UTILITY(U,$J,358.3,45068,2)
- ;;=^5001634
- ;;^UTILITY(U,$J,358.3,45069,0)
- ;;=C84.16^^170^2245^30
- ;;^UTILITY(U,$J,358.3,45069,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,45069,1,3,0)
- ;;=3^Sezary Disease,Intrapelvic Lymph Nodes
- ;;^UTILITY(U,$J,358.3,45069,1,4,0)
- ;;=4^C84.16
- ;;^UTILITY(U,$J,358.3,45069,2)
- ;;=^5001637
- ;;^UTILITY(U,$J,358.3,45070,0)
- ;;=C84.12^^170^2245^31
- ;;^UTILITY(U,$J,358.3,45070,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,45070,1,3,0)
- ;;=3^Sezary Disease,Intrathoracic Lymph Nodes
- ;;^UTILITY(U,$J,358.3,45070,1,4,0)
- ;;=4^C84.12
- ;;^UTILITY(U,$J,358.3,45070,2)
- ;;=^5001633
- ;;^UTILITY(U,$J,358.3,45071,0)
- ;;=C84.14^^170^2245^25
- ;;^UTILITY(U,$J,358.3,45071,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,45071,1,3,0)
- ;;=3^Sezary Disease,Axilla/Upper Limb Lymph Nodes
- ;;^UTILITY(U,$J,358.3,45071,1,4,0)
- ;;=4^C84.14
- ;;^UTILITY(U,$J,358.3,45071,2)
- ;;=^5001635
- ;;^UTILITY(U,$J,358.3,45072,0)
- ;;=C84.11^^170^2245^27
- ;;^UTILITY(U,$J,358.3,45072,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,45072,1,3,0)
- ;;=3^Sezary Disease,Head/Face/Neck Lymph Nodes
- ;;^UTILITY(U,$J,358.3,45072,1,4,0)
- ;;=4^C84.11
- ;;^UTILITY(U,$J,358.3,45072,2)
- ;;=^5001632
- ;;^UTILITY(U,$J,358.3,45073,0)
- ;;=C84.15^^170^2245^28
- ;;^UTILITY(U,$J,358.3,45073,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,45073,1,3,0)
- ;;=3^Sezary Disease,Inguinal Region/LE Lymph Nodes
- ;;^UTILITY(U,$J,358.3,45073,1,4,0)
- ;;=4^C84.15
- ;;^UTILITY(U,$J,358.3,45073,2)
- ;;=^5001636
- ;;^UTILITY(U,$J,358.3,45074,0)
- ;;=C84.18^^170^2245^32
- ;;^UTILITY(U,$J,358.3,45074,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,45074,1,3,0)
- ;;=3^Sezary Disease,Multiple Site Lymph Nodes
- ;;^UTILITY(U,$J,358.3,45074,1,4,0)
- ;;=4^C84.18
- ;;^UTILITY(U,$J,358.3,45074,2)
- ;;=^5001639
- ;;^UTILITY(U,$J,358.3,45075,0)
- ;;=C84.17^^170^2245^33
- ;;^UTILITY(U,$J,358.3,45075,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,45075,1,3,0)
- ;;=3^Sezary Disease,Spleen
- ;;^UTILITY(U,$J,358.3,45075,1,4,0)
- ;;=4^C84.17
- ;;^UTILITY(U,$J,358.3,45075,2)
- ;;=^5001638
- ;;^UTILITY(U,$J,358.3,45076,0)
- ;;=C84.10^^170^2245^34
- ;;^UTILITY(U,$J,358.3,45076,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,45076,1,3,0)
- ;;=3^Sezary Disease,Unspec Site
- ;;^UTILITY(U,$J,358.3,45076,1,4,0)
- ;;=4^C84.10
- ;;^UTILITY(U,$J,358.3,45076,2)
- ;;=^5001631
- ;;^UTILITY(U,$J,358.3,45077,0)
- ;;=A53.9^^170^2245^50
- ;;^UTILITY(U,$J,358.3,45077,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,45077,1,3,0)
- ;;=3^Syphilis,Unspec
- ;;^UTILITY(U,$J,358.3,45077,1,4,0)
- ;;=4^A53.9
- ;;^UTILITY(U,$J,358.3,45077,2)
- ;;=^5000310
- ;;^UTILITY(U,$J,358.3,45078,0)
- ;;=I87.2^^170^2245^41
- ;;^UTILITY(U,$J,358.3,45078,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,45078,1,3,0)
- ;;=3^Stasis Dermatitis NOS
- ;;^UTILITY(U,$J,358.3,45078,1,4,0)
- ;;=4^I87.2
- ;;^UTILITY(U,$J,358.3,45078,2)
- ;;=^5008047
- ;;^UTILITY(U,$J,358.3,45079,0)
- ;;=L90.5^^170^2245^18
- ;;^UTILITY(U,$J,358.3,45079,1,0)
- ;;=^358.31IA^4^2
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2TS 3781 printed Feb 19, 2025@00:02:07 Page 2
- IBDEI2TS ; ; 04-FEB-2020
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- +2 if 'DIFQR(358.3)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.3,45067,1,0)
- +2 ;;=^358.31IA^4^2
- +3 ;;^UTILITY(U,$J,358.3,45067,1,3,0)
- +4 ;;=3^Sezary Disease,Extranodal/Solid Organ Sites
- +5 ;;^UTILITY(U,$J,358.3,45067,1,4,0)
- +6 ;;=4^C84.19
- +7 ;;^UTILITY(U,$J,358.3,45067,2)
- +8 ;;=^5001640
- +9 ;;^UTILITY(U,$J,358.3,45068,0)
- +10 ;;=C84.13^^170^2245^29
- +11 ;;^UTILITY(U,$J,358.3,45068,1,0)
- +12 ;;=^358.31IA^4^2
- +13 ;;^UTILITY(U,$J,358.3,45068,1,3,0)
- +14 ;;=3^Sezary Disease,Intra-Abdominal Lymph Nodes
- +15 ;;^UTILITY(U,$J,358.3,45068,1,4,0)
- +16 ;;=4^C84.13
- +17 ;;^UTILITY(U,$J,358.3,45068,2)
- +18 ;;=^5001634
- +19 ;;^UTILITY(U,$J,358.3,45069,0)
- +20 ;;=C84.16^^170^2245^30
- +21 ;;^UTILITY(U,$J,358.3,45069,1,0)
- +22 ;;=^358.31IA^4^2
- +23 ;;^UTILITY(U,$J,358.3,45069,1,3,0)
- +24 ;;=3^Sezary Disease,Intrapelvic Lymph Nodes
- +25 ;;^UTILITY(U,$J,358.3,45069,1,4,0)
- +26 ;;=4^C84.16
- +27 ;;^UTILITY(U,$J,358.3,45069,2)
- +28 ;;=^5001637
- +29 ;;^UTILITY(U,$J,358.3,45070,0)
- +30 ;;=C84.12^^170^2245^31
- +31 ;;^UTILITY(U,$J,358.3,45070,1,0)
- +32 ;;=^358.31IA^4^2
- +33 ;;^UTILITY(U,$J,358.3,45070,1,3,0)
- +34 ;;=3^Sezary Disease,Intrathoracic Lymph Nodes
- +35 ;;^UTILITY(U,$J,358.3,45070,1,4,0)
- +36 ;;=4^C84.12
- +37 ;;^UTILITY(U,$J,358.3,45070,2)
- +38 ;;=^5001633
- +39 ;;^UTILITY(U,$J,358.3,45071,0)
- +40 ;;=C84.14^^170^2245^25
- +41 ;;^UTILITY(U,$J,358.3,45071,1,0)
- +42 ;;=^358.31IA^4^2
- +43 ;;^UTILITY(U,$J,358.3,45071,1,3,0)
- +44 ;;=3^Sezary Disease,Axilla/Upper Limb Lymph Nodes
- +45 ;;^UTILITY(U,$J,358.3,45071,1,4,0)
- +46 ;;=4^C84.14
- +47 ;;^UTILITY(U,$J,358.3,45071,2)
- +48 ;;=^5001635
- +49 ;;^UTILITY(U,$J,358.3,45072,0)
- +50 ;;=C84.11^^170^2245^27
- +51 ;;^UTILITY(U,$J,358.3,45072,1,0)
- +52 ;;=^358.31IA^4^2
- +53 ;;^UTILITY(U,$J,358.3,45072,1,3,0)
- +54 ;;=3^Sezary Disease,Head/Face/Neck Lymph Nodes
- +55 ;;^UTILITY(U,$J,358.3,45072,1,4,0)
- +56 ;;=4^C84.11
- +57 ;;^UTILITY(U,$J,358.3,45072,2)
- +58 ;;=^5001632
- +59 ;;^UTILITY(U,$J,358.3,45073,0)
- +60 ;;=C84.15^^170^2245^28
- +61 ;;^UTILITY(U,$J,358.3,45073,1,0)
- +62 ;;=^358.31IA^4^2
- +63 ;;^UTILITY(U,$J,358.3,45073,1,3,0)
- +64 ;;=3^Sezary Disease,Inguinal Region/LE Lymph Nodes
- +65 ;;^UTILITY(U,$J,358.3,45073,1,4,0)
- +66 ;;=4^C84.15
- +67 ;;^UTILITY(U,$J,358.3,45073,2)
- +68 ;;=^5001636
- +69 ;;^UTILITY(U,$J,358.3,45074,0)
- +70 ;;=C84.18^^170^2245^32
- +71 ;;^UTILITY(U,$J,358.3,45074,1,0)
- +72 ;;=^358.31IA^4^2
- +73 ;;^UTILITY(U,$J,358.3,45074,1,3,0)
- +74 ;;=3^Sezary Disease,Multiple Site Lymph Nodes
- +75 ;;^UTILITY(U,$J,358.3,45074,1,4,0)
- +76 ;;=4^C84.18
- +77 ;;^UTILITY(U,$J,358.3,45074,2)
- +78 ;;=^5001639
- +79 ;;^UTILITY(U,$J,358.3,45075,0)
- +80 ;;=C84.17^^170^2245^33
- +81 ;;^UTILITY(U,$J,358.3,45075,1,0)
- +82 ;;=^358.31IA^4^2
- +83 ;;^UTILITY(U,$J,358.3,45075,1,3,0)
- +84 ;;=3^Sezary Disease,Spleen
- +85 ;;^UTILITY(U,$J,358.3,45075,1,4,0)
- +86 ;;=4^C84.17
- +87 ;;^UTILITY(U,$J,358.3,45075,2)
- +88 ;;=^5001638
- +89 ;;^UTILITY(U,$J,358.3,45076,0)
- +90 ;;=C84.10^^170^2245^34
- +91 ;;^UTILITY(U,$J,358.3,45076,1,0)
- +92 ;;=^358.31IA^4^2
- +93 ;;^UTILITY(U,$J,358.3,45076,1,3,0)
- +94 ;;=3^Sezary Disease,Unspec Site
- +95 ;;^UTILITY(U,$J,358.3,45076,1,4,0)
- +96 ;;=4^C84.10
- +97 ;;^UTILITY(U,$J,358.3,45076,2)
- +98 ;;=^5001631
- +99 ;;^UTILITY(U,$J,358.3,45077,0)
- +100 ;;=A53.9^^170^2245^50
- +101 ;;^UTILITY(U,$J,358.3,45077,1,0)
- +102 ;;=^358.31IA^4^2
- +103 ;;^UTILITY(U,$J,358.3,45077,1,3,0)
- +104 ;;=3^Syphilis,Unspec
- +105 ;;^UTILITY(U,$J,358.3,45077,1,4,0)
- +106 ;;=4^A53.9
- +107 ;;^UTILITY(U,$J,358.3,45077,2)
- +108 ;;=^5000310
- +109 ;;^UTILITY(U,$J,358.3,45078,0)
- +110 ;;=I87.2^^170^2245^41
- +111 ;;^UTILITY(U,$J,358.3,45078,1,0)
- +112 ;;=^358.31IA^4^2
- +113 ;;^UTILITY(U,$J,358.3,45078,1,3,0)
- +114 ;;=3^Stasis Dermatitis NOS
- +115 ;;^UTILITY(U,$J,358.3,45078,1,4,0)
- +116 ;;=4^I87.2
- +117 ;;^UTILITY(U,$J,358.3,45078,2)
- +118 ;;=^5008047
- +119 ;;^UTILITY(U,$J,358.3,45079,0)
- +120 ;;=L90.5^^170^2245^18
- +121 ;;^UTILITY(U,$J,358.3,45079,1,0)
- +122 ;;=^358.31IA^4^2
